Issue 116 • March 2022 Uneven supply patterns hinder US rollout of Covid-19 antivirals How AI could unlock the medical potential of psychedelics Is price control by stealth the future for the United States? In association with Cutting the carbon footprint of pharma’s supply chain The pharmaceutical industry must reduce the carbon emissions associated with getting drugs to patients – but how? In association with 02/16/2022 12:59:05
